Anton Gueth Insider Profile
4 Followers
Anton Gueth, Director at Navidea, holds 467.58K shares in Antares Pharma (Ticker: ATRS), holds 38.92K shares in Navidea (Ticker: NAVBQ), holds 11.00K shares in Spectrum Pharmaceuticals (Ticker: SPPI).
Anton Gueth's Trading History
| ATRSAntares Pharma | Jul 09, 2021 | ― | Uninformative Sell | 429.00K | $2.61M | |
| NAVBQNavidea | Jan 08, 2016 | Director | Uninformative Buy | 20.64K | $389.18 | |
| SPPISpectrum Pharmaceuticals | Dec 21, 2012 | ― | Uninformative Buy | 113.40K | $11.33K |
You May Also Like
Anton Gueth insider profile FAQ
What is the percentage of profitable transactions made by Anton Gueth?
The percentage of profitable transactions made by Anton Gueth is 50%.
What is the average return per transaction made by Anton Gueth?
The average return per transaction made by Anton Gueth is 112.80%.
What stocks does Anton Gueth hold?
Anton Gueth holds: NAVBQ, ATRS, SPPI stocks.
What was Anton Gueth’s latest transaction?
Anton Gueth’s latest transaction was an Uninformative Sell of $429.00K.
What was Anton Gueth's most profitable transaction?
Anton Gueth’s most profitable transaction was an Informative Buy of ATRS stock on March 21, 2016. The return on the trade was 231.60%.
What is Anton Gueth's role in Navidea?
Anton Gueth's role in Navidea is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
